Fecal carbohydrate-degrading bacteria are associated with reduced incidence of lower gastrointestinal GVHD
Lower gastrointestinal graft-versus-host disease (LGI-GVHD) carries morbidity and mortality for patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT), with critical contributions from the intestinal microbiome. In a retrospective cohort of metagenomic sequencing of stool from patients with allo-HSCT (N = 90), we found that a reduction in specific Parabacteroides and Bacteroides species around the time of engraftment contributes to LGI-GVHD risk. Given the known diverse carbohydrate-degrading functionality of these bacteria, we investigated gene abundances for carbohydrate-active enzymes (CAZymes) and found that Parabacteroides merdae, P distasonis, and Bacteroides ovatus abundances were significantly correlated with CAZymes in patients who did not develop LGI-GVHD compared with those who did. The specific gene abundances of xylosidase, which contribute to the degradation of xylose-containing polysaccharides, were significantly associated with a reduced risk of LGI-GVHD. All these findings show the importance of the carbohydrate-degrading functionality of putative beneficial bacteria in mediating risk of LGI-GVHD.
Authors
- Tomo Hayase (ORCID: https://orcid.org/0009-0004-2604-1078)
- Ivonne I. Flores (ORCID: https://orcid.org/0009-0009-9905-1644)
- Rawan K. El-Himri
- Israel Glover
- Gabriela Rondón (ORCID: https://orcid.org/0000-0003-3841-3567)
- Rishika Prasad (ORCID: https://orcid.org/0000-0002-6875-0954)
- Eiko Hayase (ORCID: https://orcid.org/0000-0002-4824-8844)
- Robert R. Jenq (ORCID: https://orcid.org/0000-0002-5434-439X)
- Amin M. Alousi (ORCID: https://orcid.org/0000-0002-2498-8573)
- Jennifer Ann Wargo (ORCID: https://orcid.org/0000-0003-3438-7576)
- S. Ansar Ahmed (ORCID: https://orcid.org/0000-0003-4404-2037)
- Taylor M. Halsey (ORCID: https://orcid.org/0000-0001-8601-9949)
- Taha Al‐Juhaishi
- Aqsa Mohammed
- Jeffrey J. Molldrem (ORCID: https://orcid.org/0000-0003-1196-1715)
- Cesar Andres Diaz Arias (ORCID: https://orcid.org/0000-0002-9748-1300)
- Jennifer Karmouch (ORCID: https://orcid.org/0000-0003-1148-1535)
- Lauren McDaniel
- Alexandria Brown (ORCID: https://orcid.org/0009-0009-0345-4677)
- Eric C. Martens (ORCID: https://orcid.org/0000-0001-6681-2990)
- Maren Schmiester (ORCID: https://orcid.org/0000-0002-8713-572X)
- Mohamed A. Jamal (ORCID: https://orcid.org/0000-0003-3404-2535)
- Ashish Damania (ORCID: https://orcid.org/0009-0001-3158-2846)
- Yimei Jin (ORCID: https://orcid.org/0000-0002-4129-352X)
- Wen-Bin Tsai (ORCID: https://orcid.org/0000-0001-8210-5882)
- Altai Enkhbayar
- Chia-Chi Chang (ORCID: https://orcid.org/0009-0003-8726-6302)
- Christopher Fan (ORCID: https://orcid.org/0000-0002-7117-6885)
- Nadim J Ajami
- Richard E Champlin
- Christopher A Sanchez
- Christine B Peterson
- Elizabeth J Shpall
- Miriam R Ortega
Institutions
- Houston Methodist (US)
- City Of Hope National Medical Center (US)
- The University of Texas MD Anderson Cancer Center (US)
- Baylor College of Medicine (US)
- Cornell University (US)
- University of Michigan (US)
- Methodist Hospital (US)
- University of Oklahoma Health Sciences Center (US)
Publication Details
- Journal
- Blood Advances
- Published
- 2026-01-20
- DOI
- https://doi.org/10.1182/bloodadvances.2025016780
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 0.00